New patent for Incyte Corp’s drug PEMAZYRE – DrugPatentWatch
Annual Drug Patent Expiration for PEMAZYRE
Pemazyre is a drug marketed by Incyte Corp and included in one NDA. It is available from a single supplier. There are three patents protecting this drug.
This drug has one hundred and eight patent family members in thirty eight countries.
The generic ingredient in PEMAZYRE is pemigatinib. One registered supplier for this compound. Additional details are available on the pemigatinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patents for Incyte Corp.’s PEMAZYRE drug
